NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
January 5, 2026 — SaveRxCanada.to now offers Ozempic from India at prices starting around $280, saving U.S. patients over $700 per pen compared to retail pharmacies. Learn about affordable prescription options.
January 5, 2026 — Alcanza Clinical Research acquires Tampa Bay Medical Research, expanding clinical trial access. Dr. Sureka Bollepalli joins Alcanza's network of 25+ research facilities nationwide.
January 4, 2026 — Rice Orthodontics in Paducah, KY offers personalized Invisalign treatments with advanced technology, flexible financing, and a patient-focused approach for effective clear aligner care.
January 1, 2026 — Kemal Erkan surpasses 200K YouTube subscribers in 2025, expanding digital healthcare outreach with discussions on bariatric surgery, US economics, and policy impacts.
January 1, 2026 — BioUtah announces new board leadership with Erin Barry as chair and Andrew Hemmert as vice chair, plus three new board members. Changes take effect January 2026 for Utah's life sciences trade association.
December 31, 2025 — Ethema Health Corporation and Addiction Recovery Care LLC mutually terminate partnership LOI. Learn about the impact on addiction treatment services and company growth strategies in Florida and Kentucky.
December 31, 2025 — Nutriband CEO updates shareholders on 2025 achievements & 2026 outlook for AVERSA™ Fentanyl, an abuse-deterrent opioid patch. Includes FDA progress, patents, and financial strategy.
December 31, 2025 — Profound Medical raises $36M to expand AI-guided prostate treatment TULSA-PRO, a non-invasive therapy for cancer and BPH. Funding supports sales growth and R&D.
December 31, 2025 — Taiwan researchers discover blocking RUNX2 gene regulator may restore immune responses in cancer patients who stop benefiting from immunotherapy, potentially revolutionizing cancer treatment approaches.
December 31, 2025 — Capitol City Residential Health Care reveals how person-centered planning reduces behavioral crises by 40-60% for individuals with disabilities, emphasizing prevention over reaction.
December 31, 2025 — NCL relaunches Level Off metabolic supplement with loquat leaf extract for glucose support. Clean-label formula with antioxidant blend, third-party tested, available at naturalcurelabs.com.
December 30, 2025 — Lionheart Health files patent for bioelectric platform boosting peptide delivery by 300%. Technology enhances oral, topical & injectable peptide absorption for longevity applications.
December 30, 2025 — Top 10 wellness and longevity companies ranked by verified outcomes, not hype. Wellness Eternal's Biohacking Index focuses on clinical efficacy and consumer reviews for 2026 amplification.
December 30, 2025 — Med Clinic Authority expands its healthcare infrastructure platform to help providers launch and scale compliant telehealth clinics efficiently, reducing regulatory risks and operational friction.
December 30, 2025 — Freedom at The Mat launches AI-generated brand anthem "Grace As I Grow," designed for theta brainwave relaxation. Available for streaming and in New Orleans classes.
December 29, 2025 — Tonix Pharmaceuticals advances TNX-4800, a once-yearly antibody for Lyme disease prevention. No FDA-approved vaccines exist currently. Company plans FDA meeting in 2026 for Phase 2/3 development.
December 29, 2025 — Tonix Pharmaceuticals raises $20M in direct offering with Point72 to fund drug commercialization and pipeline development, including treatments for fibromyalgia and rare diseases.
December 29, 2025 — Nutriband sells 90% of Pocono Pharmaceutical to EarthVision Bio for $5M to fund development of AVERSA Fentanyl, the world's first abuse-deterrent fentanyl patch with $80-200M annual sales potential.
December 29, 2025 — Brain tumors are the leading cause of pediatric cancer deaths. Learn about new treatments from CNS Pharmaceuticals and expert views on lifestyle factors affecting young people's brain health.
December 29, 2025 — Branded Legacy (OTC: BLEG) eliminates $1M legacy debt under new leadership, improving balance sheet and reducing dilution risk for shareholders in addiction treatment sector.